Download on the App Store

Android app coming soon

Want to know when it's ready? Get notified

100.ca · Thursday, November 19, 2026 · Simplified Version · Saskatchewan

Saskatchewan will pay for two drugs for advanced ovarian cancer

Ovarian cancer starts in the ovaries, which make a woman's eggs. Starting December 1, Saskatchewan's drug plan will pay for two medicines for it. They are called Keytruda and Elahere. Only some women can get them. Their cancer must be advanced or platinum-resistant. Platinum-resistant means some common cancer drugs no longer work. They must have finished one earlier treatment and pass a special test. The province expects only eight to 10 women to qualify each year. The Saskatchewan Cancer Agency says the drugs can slow the cancer. Sometimes they help patients live longer. A patient group had asked for this.

100 wordsSource: CBC News, by Colleen Silverthorn

← The full Simplified briefing for this day · Subscribe by Email